• Keiko Mamiya, Hiroki Iida, Masako Iseki, Shigeki Yamaguch, Hiroshi Yonekura, Hiroshi Ueno, Toshifumi Kosugi, Takeshi Sasara, Yumiko Takao, Toshifumi Takasusuki, Saori Hashiguchi, Naomi Hirakawa, Yoko Sugiyama, Keiko Yamada, and Kenji Yamamoto.
• Division of Palliative Medicine, Shinshu Cancer Center, Shinshu University Hospital, 3-1-1 Asahi, Matsumoto, 390-8621, Japan. keiko@shinshu-u.ac.jp.
• J Anesth. 2024 Dec 4.

AbstractIn September 2023, the Japan Society of Pain Clinicians (JSPC) issued this consensus statement on chronic pain treatment in cancer survivors. With recent advances in the early diagnosis and treatment of cancer, its prognosis has improved, so prolonged pain in cancer survivors is considered to represent chronic pain and should be addressed. In this statement, we emphasize that not all cancer survivor pain is cancer pain. Pain that is not cancer pain should be managed with analgesics other than opioids and nerve blocks, and pain that persists despite this approach should be treated as non-cancer chronic pain so as to prevent opioid overuse. In addition, cancer survivors at any stage of disease have a potentially life-threatening condition and constantly carry the fear of cancer recurrence. Therefore, even non-cancer pain should not be treated in the same way as general chronic pain, but should be managed with consideration of emotional distress. In the future, we plan to create educational tools for healthcare professionals and to conduct online seminars, both with the goal of providing cancer survivors with appropriate assessment and treatment of chronic pain.© 2024. The Author(s).

3 keywords...

hide…